New Psychoactive Substances: Risks and Challenges
Keywords:
New psychoactive substances (NPS), Centre for Drugs and Drug Addiction (EMCDDA)Abstract
New psychoactive substances (NPS) have emerged in the last few years in response to market trends and legislative control. Only in the EU, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) reported in its European Drug Report 2016 the monitoring of more than 560 novel substances, of which 380 (70%) were detected in the past 5 years.
Downloads
Published
2017-05-25
How to Cite
Soria Sanchez Ma. Luisa. (2017). New Psychoactive Substances: Risks and Challenges. Toxicology and Forensic Medicine, 2(2), 39–40. Retrieved from https://openventio.us/index.php/TFM/article/view/472
Issue
Section
Articles
